CABALETTA BIO INC. -
4.5800
07-November-24 15:59:57
15 minutes delayed
Stocks
-0.0700
-1.51%
Today's range
4.4500 - 4.7400
ISIN
N/A
Source
NASDAQ
-
02 Oct 2023 07:00:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
19 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Participate in Multiple Upcoming Investor Conferences in September
30 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
22 Aug 2023 08:00:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
10 Aug 2023 07:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the Jefferies Healthcare Conference
31 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
22 May 2023 16:30:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio Announces Pricing of Public Offering of Common Stock
17 May 2023 22:16:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio Announces Proposed Public Offering of Common Stock
17 May 2023 16:01:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Myositis
16 May 2023 07:00:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio Reports First Quarter 2023 Financial Results and Provides Business Update
11 May 2023 07:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting
02 May 2023 16:35:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio Receives FDA Fast Track Designation for CABA-201
01 May 2023 07:00:00 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
25 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
13 Apr 2023 16:30:00 By Nasdaq GlobeNewswire
-
31 Mar 2023 07:00:00 By Nasdaq GlobeNewswire
-
16 Mar 2023 07:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the Cowen 43rd Annual Health Care Conference
28 Feb 2023 08:00:02 By Nasdaq GlobeNewswire
-
Cabaletta Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
05 Jan 2023 08:00:01 By Nasdaq GlobeNewswire
-
Cabaletta Bio Announces $35 Million Offering
08 Dec 2022 07:00:00 By Nasdaq GlobeNewswire